Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Comparative studies of fluorinated pyrimidines with various cell lines.

× No keyword cloud information.

16 in total

1. Molecular structure and effects of intermolecular hydrogen bonding on the vibrational spectrum of trifluorothymine, an antitumor and antiviral agent.

Authors: Cağrı Cırak; Nurettin Koç
Journal: J Mol Model Date: 2012-05-27 Impact factor: 1.810

2. HEp-2 cell- and herpes simplex virus type 1- induced deoxythymidine kinases: inhibition by derivatives of 5-trifluoromethyl-2'-deoxyuridine.

Authors: B L Wigdahl; J R Parkhurst
Journal: Antimicrob Agents Chemother Date: 1978-09 Impact factor: 5.191

3. Trifluorothymidine exhibits potent antitumor activity via the induction of DNA double-strand breaks.

Authors: Norihiko Suzuki; Fumio Nakagawa; Mamoru Nukatsuka; Masakazu Fukushima
Journal: Exp Ther Med Date: 2011-03-21 Impact factor: 2.447

4. Biological effects of 5-carboxy-2'-deoxyuridine: hydrolysis product of 5-trifluoromethyl-2'-deoxyuridine.

Authors: D W Clough; B L Wigdahl; J R Parkhurst
Journal: Antimicrob Agents Chemother Date: 1978-07 Impact factor: 5.191

5. Comparison of 5-FU versus FUDR activity in human colorectal cancer using an in vitro clonogenic assay (HTCA).

Authors: M Flentje; D Flentje; P Schlag
Journal: Cancer Chemother Pharmacol Date: 1986 Impact factor: 3.333

6. Metabolism and mechanism of action of 5-fluorodeoxycytidine.

Authors: E M Newman; D V Santi
Journal: Proc Natl Acad Sci U S A Date: 1982-11 Impact factor: 11.205

7. Inhibition of human cytomegalovirus by trifluorothymidine.

Authors: S A Spector; M Tyndall; E Kelley
Journal: Antimicrob Agents Chemother Date: 1983-01 Impact factor: 5.191

8. Experimental herpes simplex virus type 1 encephalitis: treatment with 5-trifluoromethyl-2'-deoxyuridine.

Authors: D W Clough; J R Parkhurst
Journal: Antimicrob Agents Chemother Date: 1977-02 Impact factor: 5.191

9. Antitumor activity of FTC-092, a masked 5-trifluoromethyl-2'-deoxyuridine derivative.

Authors: S Takeda; J Yamashita; H Saito; J Uchida; H Satake; Y Yamada; N Unemi; Y Wataya; H Hayatsu
Journal: Cancer Chemother Pharmacol Date: 1991 Impact factor: 3.333

Review 10. Trifluridine: a review of its antiviral activity and therapeutic use in the topical treatment of viral eye infections.

Authors: A A Carmine; R N Brogden; R C Heel; T M Speight; G S Avery
Journal: Drugs Date: 1982-05 Impact factor: 9.546